Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Effectiveness of Bupropion on Sexual Dysfunction of Women With Multiple Sclerosis: A Clinical Trial Publisher



Yavari F1 ; Salehi M1 ; Mirmosayyeb O2 ; Tarrahi MJ3 ; Barekatain M1 ; Shaygannejad V4 ; Ashtari F4 ; Mollaeinezhad M5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Psychiatry, Behavioral Sciences Research Center, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Neuroscience Research Center, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Neurology, Neuroscience Research Center, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Department of Research, Behavioral Sciences Research Center, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Iranian Journal of Obstetrics, Gynecology and Infertility Published:2021


Abstract

Introduction: Sexual dysfunctions are relatively prevalent in female patients with multiple sclerosis (MS) and affect their quality of life. This study was performed with aim to evaluate the effect of Bupropion on sexual function in women with multiple sclerosis. Methods: This randomized controlled clinical trial study was performed in 2019 on 60 women with relapsing and remitting MS, receiving routine MS treatment and had sexual dysfunction. The subjects were divided to two groups of 30 persons receiving Bupropion and placebo. Multiple sclerosis intimacy and sexuality questionnaire, female sexual function index, fatigue severity scale and Beck depression questionnaire were filled out for all the patients before, 4 and 8 weeks after the interventions initiation. Data were analyzed by SPSS software (version 20) and Analysis of variance (AOVA) and repeated measure tests. P<0.05 was considered statistically significant. Results: Multiple sclerosis intimacy and sexuality scores 8 weeks after the intervention were significantly lower in bupropion group (9.96±45.85) compared to placebo group (53.56±11.46) (P= 0.007). Also, the score of depression in the two stages after the intervention in the bupropion group (11.26 ± 23.03) was lower than the placebo group (37.86 ± 13.43) and decreased during the intervention (p <0.0001). FSFI score and its subscales showed an improvement in bupropion group (2.67±25.88) compared with placebo group (17.44±2.8) which indicated continuity of effectiveness of Bupropion independently from depression and fatigue scores alteration during treatment (p<0.001). Conclusion: The results of the present study showed the effectiveness of bupropion on improvement of sexual function in female patients with MS. © 2021, Mashhad University of Medical Sciences. All rights reserved.
Related Docs
View other Related Docs
1. Sexual Dysfunction in Women With Multiple Sclerosis: Prevalence and Impact on Quality of Life, BMC Urology (2020)
2. Prevalence of Sexual Dysfunction and Related Risk Factors in Men With Multiple Sclerosis in Iran: A Multicenter Study, Neurology and Therapy (2021)
3. Sexual Dysfunction in Women With Multiple Sclerosis: Dimensions and Contributory Factors, Journal of Research in Medical Sciences (2014)
4. Sexual Dysfunction in Women With Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis, Sexuality and Disability (2022)
5. Prevalence and Risk of Developing Sexual Dysfunction in Women With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, BMC Women's Health (2023)
6. The Effect of Counseling Based on the Plissit Model on Sexual Quality of Life of Married Women With Multiple Sclerosis Referring to Ms Center in 2019: A Randomized, Controlled Trial, Archives of Women's Mental Health (2021)
7. Sexual Function and Related Predictors in Male With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Case–Control Study, Journal of Sexual Medicine (2025)
8. The Effectiveness of Bupropion on the Sexual Function in Women With Orgasmic Disorders: A Pilot Study, Journal of Isfahan Medical School (2019)
Experts (# of related papers)
View all Related Experts
Vahid Shaygannejad (77)
Masoud Etemadifar (52)
Other Related Docs
9. The Prevalence of Sexual Dysfunction and Erectile Dysfunction in Men With Multiple Sclerosis: A Systematic Review and Meta-Analysis; [La Prevalencia De La Disfuncion Sexual Y La Disfuncion Erectil En Hombres Con Esclerosis Multiple: Una Revision Sistematica Y Metanalisis], Neurologia (2025)
10. The Effect of Maintenance Treatment With Methadone and Buprenorphine on Sexual Function of Females Addicted to Opiates, Iranian Journal of Obstetrics, Gynecology and Infertility (2021)
11. Lateonset Multiple Sclerosis in Isfahan, Iran, Archives of Iranian Medicine (2012)
12. Male Sex Is Independently Associated With Faster Disability Accumulation in Relapse-Onset Ms But Not in Primary Progressive Ms, PLoS ONE (2015)
13. Sex As a Determinant of Relapse Incidence and Progressive Course of Multiple Sclerosis, Brain (2013)
14. Evaluation of Plasma Soluble Cd137 Level in Relapsing-Remitting Multiple Sclerosis Patients in Comparison With Healthy Controls in Isfahan Province, Iran, Neurology Asia (2020)
15. Bupropion Efficacy on Sexual Dysfunction Among Male Patients on Methadone Maintenance Therapy: A Double-Blind Placebo-Controlled Trial, Sexual and Relationship Therapy (2015)
16. Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis: A Randomized Clinical Trial, Acta Neurologica Scandinavica (2021)
17. Confirmed Disability Progression As a Marker of Permanent Disability in Multiple Sclerosis, European Journal of Neurology (2022)
18. Sharp Increase in the Incidence and Prevalence of Multiple Sclerosis in Isfahan, Iran, Multiple Sclerosis Journal (2011)
19. Reciprocal Effects of Multiple Sclerosis, Childbirth, and Postpartum, Iranian Journal of Neonatology (2018)
20. The Effect of Group Cognitive Behavioral Therapy on Stress, Anxiety, and Depression of Women With Multiple Sclerosis, Iranian Journal of Nursing and Midwifery Research (2017)
21. Effectiveness of Cognitive Behavioral Therapy on the Quality of Sleep in Women With Multiple Sclerosis: A Randomized Controlled Trial Study, International Journal of Community Based Nursing and Midwifery (2016)
22. Better Prognosis of Multiple Sclerosis in Patients Who Experienced a Full-Term Pregnancy, European Neurology (2012)
23. Effects of Resistance Training and Vibration on Hormonal Changes in Female Patients With Multiple Sclerosis, Neurology Asia (2014)
24. Anti-Inflammatory-Antioxidant Modifications and Synbiotics Improved Health-Related Conditions in Patients With Progressive Forms of Multiple Sclerosis: A Single-Center, Randomized Clinical Trial, Complementary Therapies in Clinical Practice (2023)
25. Risk Factors of Early Onset of Ms in Women in Reproductive Age Period: Survival Analysis Approach, Archives of Women's Mental Health (2016)
26. Evaluating Sex Hormone Levels in Reproductive Age Women With Multiple Sclerosis and Their Relationship With Disease Severity, Journal of Research in Medical Sciences (2012)
27. Investigating the Interaction Between Fertility, Pregnancy, and Multiple Sclerosis, Journal of Education and Health Promotion (2021)
28. Assessing the Risk Factors for Multiple Sclerosis in Women of Reproductive Age Suffering the Disease in Isfahan Province, International Journal of Preventive Medicine (2016)
29. First-Year Treatment Response Predicts the Following 5-Year Disease Course in Patients With Relapsing-Remitting Multiple Sclerosis, Neurotherapeutics (2025)
30. The Prevalence of Lower Urinary Tract Symptoms Based on Individual and Clinical Parameters in Patients With Multiple Sclerosis, BMC Neurology (2020)
31. Stress Differentially Predicts Multiple Sclerosis Relapses, Neurology Asia (2014)
32. The Frequency of Cognitive Dysfunction Among Multiple Sclerosis Patients With Mild Physical Disability, Journal of Isfahan Medical School (2012)
33. The Effect of Mindfulness-Based Stress Reduction (Mbsr) Therapy on Quality of Life in Women With Multiple Sclerosis, Ahvaz, Iran, Journal of Caring Sciences (2019)
34. Risk Factors of Multiple Sclerosis and Their Relation With Disease Severity: A Cross-Sectional Study From Iran, Archives of Iranian Medicine (2016)
35. Multiple Sclerosis-Related Fatigue Lacks a Unified Definition: A Narrative Review, Journal of Research in Medical Sciences (2022)
36. Comparing the Effects of Reflexology and Relaxation on Fatigue in Women With Multiple Sclerosis, Iranian Journal of Nursing and Midwifery Research (2015)
37. The Study of Circadian Rhythms Disorder and Its Relationship With Chronic Fatigue in Multiple Sclerosis in Compare With Control Group, Journal of Isfahan Medical School (2011)
38. The Prevalence of Restless Legs Syndrome (Rls) in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis—An Update, Neurological Sciences (2023)
39. The Effectiveness of Natalizumab Vs Fingolimod–A Comparison of International Registry Studies, Multiple Sclerosis and Related Disorders (2021)
40. Barriers to Quality of Life in Patients With Multiple Sclerosis: A Qualitative Study, BMC Neurology (2022)
41. Does Significant Weight Loss After Bariatric Surgery Affect Sexual Function and Urinary Symptoms? an Iranian Study, Obesity Surgery (2023)
42. Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis, JAMA - Journal of the American Medical Association (2019)
43. Connection of Mir-185 and Mir-320A Expression Levels With Response to Interferon-Beta in Multiple Sclerosis Patients, Multiple Sclerosis and Related Disorders (2020)
44. Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years, Neurology (2021)
45. Prevalence of Cognitive Impairment (Ci) in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Caspian Journal of Internal Medicine (2024)
46. Comparative Study of Quality of Life, Anxiety, Depression, and Fatigue Among Patients With Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: The First Report From Iran, Multiple Sclerosis and Related Disorders (2018)
47. A Comprehensive Interventional Program to Improve the Sexual Function of Women With Endometriosis: A Mixed-Methods Protocol Study, Reproductive Health (2024)
48. Risk Factors of Severe Covid-19 in People With Multiple Sclerosis : A Systematic Review and Meta-Analysis, Revue Neurologique (2022)
49. Stability of Mental Toughness, Sleep Disturbances, and Physical Activity in Patients With Multiple Sclerosis (Ms)-A Longitudinal and Pilot Study, Frontiers in Psychiatry (2018)
50. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)